برجاء استخدام كلمات أخرى للبحث
اسم | العنوان | منذ | حتى |
---|---|---|---|
Stephen Kelly | Portfolio Manager | 2021 | الآن |
السيرة الذاتية | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
Peter Hughes | Portfolio Manager | 2021 | الآن |
السيرة الذاتية | Peter is a Portfolio Manager in our Framlington Equities expertise and has specialised in bi-otech and longevity within its global strategies since joining the firm in 2015. Prior to AXA IM, Peter worked at Architas in roles covering investment research and relationship man-agement. Peter completed a PhD in biochemistry at University College London, working on a drug development project in a multidisciplinary research group collaborating with GSK. He has a master's degree in chemistry from the University of Surrey and holds the Investment Man-agement Certificate. He is also an ambassador for the Royal Marsden Cancer Charity. | ||
Linden Thomson | - | 2015 | 2021 |
Dani Saurymper | - | 2015 | 2021 |
السيرة الذاتية | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
Gemma Game | - | 2009 | 2015 |
Deane Donnigan | clinical Specialist | 2007 | 2008 |
السيرة الذاتية | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. |
هل أنت تريك بالتأكيد الحظر %USER_NAME%؟
إن قيامك بهذا يعني أنك و%USER_NAME% لن تكونا قادرين على رؤية مشاركات الأخرى على Investing.com.
لقد تم إضافة %USER_NAME% بنجاح إلى قائمة الحظر
بما أنك قد قمت برفع الحظر للتو عن هذا الشخص، فإنه يتوجب عليك الإنتظار 48 ساعة قبل أن تتمكن من تجديد الحظر.
أخبرنا كيف تشعر حيال هذا التعليق
شكرا جزيلا
تم إرسال تقريرك إلى مشرفينا لمراجعته